No Data
No Data
Cantor Fitzgerald Maintains Korro Bio(KRRO.US) With Buy Rating, Cuts Target Price to $74
Cantor Fitzgerald Initiates Korro Bio at Overweight $74 Price Target
New Analyst Forecast: $KRRO Given 'Overweight' Rating
Chardan Capital Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $25
This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Express News | Korro Bio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Price Target $25